São Paulo - Delayed Quote • BRL
Brasil Pharma S.A. (BPHA3.SA)
At close: June 10 at 5:05 PM GMT-3
Breakdown
TTM
Total Revenue
8,466.0000
Cost of Revenue
168.0000
Gross Profit
8,298.0000
Operating Expense
31,892.0000
Operating Income
-23,594.0000
Net Non Operating Interest Income Expense
1,067,770.0000
Pretax Income
1,145,010.0000
Tax Provision
-7,458.0000
Net Income Common Stockholders
1,176,492.0000
Diluted NI Available to Com Stockholders
1,176,492.0000
Basic EPS
10.40
Diluted EPS
10.40
Basic Average Shares
113,081.1270
Diluted Average Shares
113,081.1270
Total Expenses
32,060.0000
Net Income from Continuing & Discontinued Operation
1,176,492.0000
Normalized Income
1,151,499.1200
Interest Income
1,055,447.0000
Interest Expense
6,508.0000
Net Interest Income
1,067,770.0000
EBIT
1,151,518.0000
EBITDA
1,161,351.0000
Reconciled Cost of Revenue
168.0000
Reconciled Depreciation
9,833.0000
Net Income from Continuing Operation Net Minority Interest
1,152,468.0000
Total Unusual Items Excluding Goodwill
1,468.0000
Total Unusual Items
1,468.0000
Normalized EBITDA
1,159,883.0000
Tax Rate for Calcs
0.0003
Tax Effect of Unusual Items
499.1200
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade